Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action

Vijaya Raj Bhatt, Geoffrey L. Uy, Heidi D. Klepin

Blood (2024) 143 (6): 483–487.

https://doi.org/10.1182/blood.2023022611

Published: 2024

Includes: Supplemental data

Journal Articles

Toward consensus on geriatric assessment in AML

Heidi D. Klepin

Blood (2022) 139 (11): 1605–1606.

https://doi.org/10.1182/blood.2021015200

Published: 2022

Journal Articles

Assessment of an Embedded Primary Care-Derived Electronic Health Record Frailty Index (eFI) in Older Adults with Acute Myeloid Leukemia

Justin J. Cheng, Janet A. Tooze, Kathryn E. Callahan, Nicholas M. Pajewski, Timothy S. Pardee, Daniel R. Reed, Heidi D. Klepin

Blood (2021) 138 (Supplement 1): 1941.

https://doi.org/10.1182/blood-2021-152464

Published: 2021

Journal Articles

Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia

Mohammed Saad, Kah Poh Loh, Janet A. Tooze, Timothy S. Pardee, Leslie R. Ellis, Bayard L. Powell, Rupali Roy Bhave, Ann M. Geiger, Jeff D. Williamson, Stephen Kritchevsky, Heidi D. Klepin

Blood (2020) 136 (23): 2715–2719.

https://doi.org/10.1182/blood.2020005498

Published: 2020

Journal Articles

Decisional Involvement, Information Preferences, and Prognostic Optimism Among Patients with Hematologic Malignancies

Kah Poh Loh, MBBCHBAO, Mazie Tsang, MD, Thomas W. Leblanc, Anthony Back, MD, Paul Duberstein, PhD, Supriya G. Mohile, MD MS, Ronald Epstein, MD, Heidi D. Klepin, MDMS, Michael W. Becker, MD, Areej El-Jawahri, MD, Stephanie J. Lee, MDMPH

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-134157

Published: 2020

Journal Articles

Feasibility of Peri-Transfusion Quality of Life Assessment for Patients with Myelodysplastic Syndromes

Gregory A. Abel, MD MPH, Heidi D. Klepin, MDMS, Emily S. Magnavita, MPH, Tim Jaung, MS, Rory M. Shallis, MD, Nupur E. Bahl, Rebecca Dellinger-Johnston, Eric S. Winer, MD, Amer M. Zeidan, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-139919

Published: 2020

Journal Articles

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Heidi D. Klepin

Blood (2019) 134 (23): 2005–2012.

https://doi.org/10.1182/blood.2019001299

Published: 2019

Journal Articles

Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Intensive Induction Chemotherapy

Geoffrey L. Uy, MD, Jun Yin, PhD, Heidi D. Klepin, MD, Shira Dinner, MD, Anthony J. Jaslowski, MD, Stephen A. Strickland, MD, Jane L. Liesveld, MD, John C. Byrd, MD, Richard M. Stone, MD

Blood (2019) 134 (Supplement_1): 1366.

https://doi.org/10.1182/blood-2019-127142

Published: 2019

Journal Articles

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Jordon Jaggers, Heidi D. Klepin, MD, Tanya M. Wildes, MD, Rebecca L. Olin, MD, Andrew S. Artz, MD, Sarah A Wall, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 5819.

https://doi.org/10.1182/blood-2019-131504

Published: 2019

Journal Articles

Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Heidi D. Klepin, MD MS, Avrita Campinha-Bacote, Wan-Jen Hong, Patrick Phuong, Jue Wang, Mehrdad Mobasher, MD MPH, Peter Trask

Blood (2018) 132 (Supplement 1): 4076.

https://doi.org/10.1182/blood-2018-99-116038

Published: 2018

Journal Articles

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Kah Poh Loh, MBBCHBAO, Sindhuja Kadambi, MD, Supriya G. Mohile, MD MS, Jason H. Mendler, MD PhD, Jane L. Liesveld, MD, Kristen M. O'Dwyer, MD, Michael W. Becker, MD, Colin M. McHugh, MD, Marsha Wittink, MD MBE, Wendy Stock, MD, Navneet S. Majhail, MD MS, Tanya Wildes, MD, Paul Duberstein, PhD, Heidi D. Klepin, MD MS

Blood (2018) 132 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2018-99-114178

Published: 2018

Journal Articles

Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus on Geriatric Population

Kah Poh Loh, MBBCHBAO, Jian Liang Tan, Colin M. McHugh, MD, Jane L. Liesveld, MD, Kristen M. O'Dwyer, MD, Michael W. Becker, MD, Jason H. Mendler, MD PhD, Omar S. Aljitawi, MD, Heidi D. Klepin, MD MS, Wendy Stock, MD, Tanya Wildes, MD, Andrew S Artz, MD, Areej El-Jawahri, MD, Navneet S. Majhail, MD MS

Blood (2018) 132 (Supplement 1): 2245.

https://doi.org/10.1182/blood-2018-99-112320

Published: 2018

Journal Articles

Frailty and the management of hematologic malignancies

Gregory A. Abel, Heidi D. Klepin

Blood (2018) 131 (5): 515–524.

https://doi.org/10.1182/blood-2017-09-746420

Published: 2018

Journal Articles

Addition of Sorafenib to Chemotherapy Improves the Overall Survival of Older Adults with FLT3 -ITD Mutated Acute Myeloid Leukemia (AML) (Alliance C11001)

Geoffrey L. Uy, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Ben Sanford, Guido Marcucci, MD, Weiqiang Zhao, MD PhD, Mark J. Levis, MD PhD, Heidi D. Klepin, MD MS, Maria R. Baer, MD, Bayard L. Powell, MD, Peter Westervelt, MD PhD, Daniel J. DeAngelo, MD PhD, Wendy Stock, MD, Clara D. Bloomfield, MD, John C. Byrd, MD, Richard M. Stone, MD, Richard A. Larson, MD

Blood (2015) 126 (23): 319.

https://doi.org/10.1182/blood.V126.23.319.319

Published: 2015

Journal Articles

Feasibility of a Symptom-Adapted Physical Activity Intervention during Induction Chemotherapy for Older Adults with Acute Myeloid Leukemia (AML)

Heidi D. Klepin, MD MS, Janet Tooze, PhD, Timothy Pardee, MD PhD, Leslie Renee Ellis, MD, Dmitriy Berenzon, MD, Dianna Howard, MD, Wendy Demark-Wahnefried, PhD, Shannon Mihalko, PhD, William Jack Rejeski, PhD, Bayard L. Powell, MD, Stephen Kritchevsky, PhD

Blood (2015) 126 (23): 2102.

https://doi.org/10.1182/blood.V126.23.2102.2102

Published: 2015

Journal Articles

High Dose Cytarabine, Mitoxantrone and L-Asparaginase (HAMA) Salvage For Relapsed Or Refractory Acute Myeloid Leukemia (AML) In The Elderly

Tamjeed Ahmed, MD, Scott Holwerda, MD, Timothy Pardee, MD, PhD, Scott Isom, MS, Susan Lyerly, PA, Leslie Renee Ellis, MD, Megan Manuel, MSN, Sarah Dralle, MSN, Berenzon Dmitriy, MD, Heidi D. Klepin, MD, MS, Bayard L. Powell, MD

Blood (2013) 122 (21): 2700.

https://doi.org/10.1182/blood.V122.21.2700.2700

Published: 2013

Journal Articles

Initial Results Of a Phase II Trial Of Sorafenib Plus Standard Induction In Older Adults With Mutant FLT3 Acute Myeloid Leukemia (AML) (Alliance trial C11001)

Geoffrey L. Uy, MD, Ben Sanford, Guido Marcucci, MD, Weiqiang Zhao, MD, PhD, Susan Geyer, PhD, Heidi D. Klepin, MD, MS, Bayard L. Powell, MD, Maria R. Baer, MD, Wendy Stock, M.D., Richard M. Stone, MD, Richard A. Larson, MD

Blood (2013) 122 (21): 2653.

https://doi.org/10.1182/blood.V122.21.2653.2653

Published: 2013

Journal Articles

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia

Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze, Stephen B. Kritchevsky, Jeff D. Williamson, Timothy S. Pardee, Leslie R. Ellis, Bayard L. Powell

Blood (2013) 121 (21): 4287–4294.

https://doi.org/10.1182/blood-2012-12-471680

Published: 2013

Journal Articles

Geriatric Assessment Predicts Overall Survival Among Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia.

Heidi D. Klepin, MD, MS, Janet A. Tooze, PhD, Ann M. Geiger, PhD, Stephen Kritchevsky, PhD, Jeff Williamson, MD, MHS, Leslie R. Ellis, MD, Denise Levitan, MD, Timothy Pardee, MD, PhD, Scott Isom, MS, Bayard L. Powell, MD

Blood (2010) 116 (21): 1535.

https://doi.org/10.1182/blood.V116.21.1535.1535

Published: 2010

Journal Articles

Inpatient Geriatric Assessment Detects Impairment Among Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia.

Heidi D Klepin, MD, MS, Ann M Geiger, PhD, Jeff Williamson, MD, MHS, Stephen Kritchevsky, PhD, Janet A Tooze, PhD, Leslie Renee Ellis, MD, Denise Levitan, MD, Scott Isom, MS, Bayard L. Powell, MD

Blood (2009) 114 (22): 1401.

https://doi.org/10.1182/blood.V114.22.1401.1401

Published: 2009

NARROW

Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action

Toward consensus on geriatric assessment in AML

Assessment of an Embedded Primary Care-Derived Electronic Health Record Frailty Index (eFI) in Older Adults with Acute Myeloid Leukemia

Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia

Decisional Involvement, Information Preferences, and Prognostic Optimism Among Patients with Hematologic Malignancies

Feasibility of Peri-Transfusion Quality of Life Assessment for Patients with Myelodysplastic Syndromes

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Intensive Induction Chemotherapy

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus on Geriatric Population

Frailty and the management of hematologic malignancies

Addition of Sorafenib to Chemotherapy Improves the Overall Survival of Older Adults with FLT3 -ITD Mutated Acute Myeloid Leukemia (AML) (Alliance C11001)

Feasibility of a Symptom-Adapted Physical Activity Intervention during Induction Chemotherapy for Older Adults with Acute Myeloid Leukemia (AML)

High Dose Cytarabine, Mitoxantrone and L-Asparaginase (HAMA) Salvage For Relapsed Or Refractory Acute Myeloid Leukemia (AML) In The Elderly

Initial Results Of a Phase II Trial Of Sorafenib Plus Standard Induction In Older Adults With Mutant FLT3 Acute Myeloid Leukemia (AML) (Alliance trial C11001)

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia

Geriatric Assessment Predicts Overall Survival Among Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia.

Inpatient Geriatric Assessment Detects Impairment Among Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only